Lola Lecru

Lola Lecru is an accomplished scientist specializing in clinical biomarkers with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Principal Scientist - Clinical Biomarker at Ipsen, Lola previously held leadership roles at Domain Therapeutics, overseeing Clinical Biomarker Strategy and Translational R&D and Biomarker efforts. Prior experience at Galapagos included positions as Scientist and Senior Scientist focused on fibrosis and translational research, where Lola defined biomarker strategies and facilitated knowledge transfer between pre-clinical and clinical settings. Early career work at Inserm involved postdoctoral research on kidney diseases and the cannabinoid system, contributing to multiple projects with leading researchers. Lola holds a Ph.D. in Physiology, Pathology and Related Sciences from Paris-Sud University and possesses a background in medication and health products.